Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Nonalcoholic Steatohepatitis (NASH) With Fibrosis”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT04634149
What this trial is testing

Evaluate the Drug Levels, Safety, and Tolerability of BMS-986036 in Participants With Normal Liver Function and Participants With Moderate and Severe Liver Impairment

Who this might be right for
Moderate Liver ImpairmentSevere Liver Impairment
Bristol-Myers Squibb 16
Testing effectiveness (Phase 2)Study completedNCT05305599
What this trial is testing

Different Doses of ZED1227 vs. Placebo in NAFLD

Who this might be right for
NAFLDLiver Fibrosis
Dr. Falk Pharma GmbH 186
Not applicableUnknownNCT03377140
What this trial is testing

The Effects of Hesperidin on Biochemical Factors and Hepatic Fibrosis in Nonalcoholic Fatty Liver Disease

Who this might be right for
Non Alcoholic Steatohepatitis
National Nutrition and Food Technology Institute 50
Not applicableStudy completedNCT04241575
What this trial is testing

Identification of Fatty Liver With Advanced Fibrosis in Type 2 Diabetes Using Simple Fibrosis Scores and Electronic Reminder Messages

Who this might be right for
Fatty Liver, NonalcoholicDiabetes Mellitus, Type 2
Chinese University of Hong Kong 1,061
Not applicableStudy completedNCT01324414
What this trial is testing

Impact of Muscle Insulin Resistance on the Pathogenesis of Non Alcoholic Steatohepatitis

Who this might be right for
Non Alcoholic Fatty Liver Diseases (NAFLD)
Mayo Clinic 90
Early research (Phase 1)Study completedNCT04559126
What this trial is testing

EDP-297 in Healthy Subjects

Who this might be right for
NASH - Nonalcoholic Steatohepatitis With Liver Fibrosis
Enanta Pharmaceuticals, Inc 82
Testing effectiveness (Phase 2)Study completedNCT03008070
What this trial is testing

Phase 2b Study in NASH to Assess IVA337

Who this might be right for
Non-Alcoholic Steatohepatitis (NASH)
Inventiva Pharma 247
Not applicableStudy completedNCT05224037
What this trial is testing

Comparative Efficacy of Liver Fibrosis and Steatosis Assessment With Fibroscan and iLivTouch

Who this might be right for
Chronic Liver DiseaseLiver FibrosisLiver Steatoses
Federal State Budgetary Scientific Institution 100
Not applicableStudy completedNCT04791397
What this trial is testing

Evaluation of the Effect of IHHT on Vascular Stiffness and Elasticity of the Liver Tissue in Patients With MS.

Who this might be right for
Vascular StiffnessLiver FibrosesMetabolic Syndrome+2 more
I.M. Sechenov First Moscow State Medical University 62
Not applicableLooking for participantsNCT05463796
What this trial is testing

InAdvance: Surveillance, Prevention, and Interception in a Population at Risk for Cancer

Who this might be right for
Cancer RiskCancer Predisposition SyndromeHereditary Cancer Prediction+28 more
Dana-Farber Cancer Institute 5,000
Testing effectiveness (Phase 2)Study completedNCT05506488
What this trial is testing

Dasatinib and Quercetin to Treat Fibrotic Non-alcoholic Fatty Liver Disease

Who this might be right for
NAFLDNASH With FibrosisLiver Fibrosis
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) 30
Testing effectiveness (Phase 2)UnknownNCT03205345
What this trial is testing

Emricasan, a Caspase Inhibitor, for Treatment of Subjects With Decompensated NASH Cirrhosis

Who this might be right for
Decompensated Cirrhosis
Conatus Pharmaceuticals Inc. 210
Testing effectiveness (Phase 2)Study completedNCT02421094
What this trial is testing

Clinical Trial to Evaluate Efficacy of GR-MD-02 for Treatment of Liver Fibrosis in Patients With NASH With Advanced Fibrosis

Who this might be right for
Nonalcoholic Steatohepatitis
Galectin Therapeutics Inc. 30
Large-scale testing (Phase 3)Ended earlyNCT03028740
What this trial is testing

AURORA: A Study for the Efficacy and Safety of Cenicriviroc (CVC) for the Treatment of Liver Fibrosis in Adults With Nonalcoholic Steatohepatitis (NASH)

Who this might be right for
Nonalcoholic Steatohepatitis
Tobira Therapeutics, Inc. 1,778
Large-scale testing (Phase 3)Active Not RecruitingNCT04951219
What this trial is testing

Evaluate Safety and Biomarkers of Resmetirom (MGL-3196) in Patients With Non-alcoholic Fatty Liver Disease (NAFLD), MAESTRO-NAFLD-Open-Label-Extension (MAESTRO-NAFLD-OLE)

Who this might be right for
Non-Alcoholic Fatty Liver Disease
Madrigal Pharmaceuticals, Inc. 810
Not applicableStudy completedNCT01874249
What this trial is testing

Non Invasive Assessment of Liver Fibrosis in Fatty Liver Disease

Who this might be right for
Non Alcoholic Fatty Liver Disease
Fundación Clínica Médica Sur 1,200
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06160271
What this trial is testing

Study of Liver Fibrosis Stage Assessment by Fibroblast Activation Protein Imaging in Patients With Biopsy for Suspected or Proven Nonalcoholic Steatohepatitis

Who this might be right for
Non-alcoholic Steatohepatitis
Central Hospital, Nancy, France 72
Not applicableLooking for participantsNCT03472157
What this trial is testing

Controlled Study Evaluating Bariatric Surgery as a Treatment for Severe NASH With Advanced Liver Fibrosis in Non-severe Obese Patients

Who this might be right for
SurgeryObesityNASH - Nonalcoholic Steatohepatitis+1 more
University Hospital, Lille 100
Not applicableNot Yet RecruitingNCT07827430
What this trial is testing

Impact of Overt and Subclinical Hypothyroidism on Liver Fibrosis in Patients With MASLD

Who this might be right for
Metabolic Dysfunction-Associated Steatotic Liver DiseaseNon-Alcoholic Fatty Liver DiseaseHypothyroidism+1 more
Assiut University 120
Not applicableUnknownNCT05257200
What this trial is testing

Gut Permeability and Bariatric-metabolic Surgery

Who this might be right for
NASH - Nonalcoholic SteatohepatitisBariatric Surgery CandidateIntestinal Permeability
Medical University of Vienna 125
Next Page